Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Aspirin and Serine

drug:

Aspirin

supplement:

Serine

Research Papers that Mention the Interaction

Aspirin , which … serine residue close to the active site,5 has been shown to reduce significantly myocardial infarction and death in four placebocontrolled, double-blind trials.… other pharmacological properties of aspirin are relevant, its efficacy has been explicable in terms of its action as an inhibitor of platelet cyclooxygenase.
Circulation  •  1990  |  View Paper
Aspirin exerts its unique pharmacological effects by irreversibly acetylating a serine residue in the cyclooxygenase site of prostaglandin-H2-synthases (PGHSs).
Biochemical pharmacology  •  2008  |  View Paper
Aspirin irreversibly acetylates a serine residue at position 529 in the human enzyme,5 close to but not at the catalytic site, though still blocking access to it by the arachidonic acid substrate.
Arteriosclerosis, thrombosis, and vascular biology  •  2000  |  View Paper
In this work, we have found that in the presence of acetylsalicylic acid , at a concentration like that used for anti-inflammatory treatments, tau phosphorylation at serine 422 decreases.
Neuroscience Letters  •  2006  |  View Paper
Aspirin acts by irreversibly acetylating a serine residue at position 530 within the channel, blocking access of arachidonic acid to its catalytic site, and preventing metabolism of arachidonic acid for the lifetime of the platelet (Figure 1B).
Circulation  •  2005  |  View Paper
Aspirin irreversibly acetylates a serine residue at position 529 in COX-1, preventing arachidonic acid from reaching the binding site.
Annals of Internal Medicine  •  2005  |  View Paper
More usefully, the multiple potential causes of treatment failure on aspirin might be pursued and named accordingly.11 Aspirin irreversibly acetylates a serine residue at position 530 on the cyclooxygenase (COX) enzyme, thus inhibiting the first step in the transformation of arachidonic acid to the platelet agonist thromboxane A2.
Circulation  •  2004  |  View Paper
Aspirin inhibits platelet function by blocking the synthesis of thromboxane A,, a vasoconstrictor and promoter of platelet aggregation, by irreversibly acetylating a serine residue, and thus inhibiting the cyclooxygenase and hydroperoxidase reactions needed for the production of thromboxane A, (6).
Anesthesia and analgesia  •  1994  |  View Paper
Acetylsalicylic acid irreversibly inhibits cyclooxygenase by acetylating a serine residue in the active site.
Bulletin of the New York Academy of Medicine  •  1989  |  View Paper
Aspirin selectively inhibits the fatty acid cyclooxygenase activity but not the PG hydroperoxidase activity by acetylating the serine #506.
Nihon rinsho. Japanese journal of clinical medicine  •  1992  |  View Paper
Show More